Ischemic Preconditioning, Myocardial
"Ischemic Preconditioning, Myocardial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Exposure of myocardial tissue to brief, repeated periods of vascular occlusion in order to render the myocardium resistant to the deleterious effects of ISCHEMIA or REPERFUSION. The period of pre-exposure and the number of times the tissue is exposed to ischemia and reperfusion vary, the average being 3 to 5 minutes.
| Descriptor ID |
D019157
|
| MeSH Number(s) |
E02.592.325 E05.516.325
|
| Concept/Terms |
Ischemic Preconditioning, Myocardial- Ischemic Preconditioning, Myocardial
- Myocardial Ischemic Preconditioning
- Preconditioning, Myocardial Ischemic
- Myocardial Preconditioning
- Preconditioning, Myocardial
|
Below are MeSH descriptors whose meaning is more general than "Ischemic Preconditioning, Myocardial".
Below are MeSH descriptors whose meaning is more specific than "Ischemic Preconditioning, Myocardial".
This graph shows the total number of publications written about "Ischemic Preconditioning, Myocardial" by people in this website by year, and whether "Ischemic Preconditioning, Myocardial" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2007 | 0 | 2 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ischemic Preconditioning, Myocardial" by people in Profiles.
-
Wu L, Li Z, Yao Y. Hydrogen peroxide preconditioning is of dual role in cardiac ischemia/reperfusion. Eur J Pharmacol. 2023 May 15; 947:175684.
-
Knutson AK, Williams AL, Boisvert WA, Shohet RV. HIF in the heart: development, metabolism, ischemia, and atherosclerosis. J Clin Invest. 2021 09 01; 131(17).
-
Wu L, Tan JL, Chen ZY, Huang G. Cardioprotection of post-ischemic moderate ROS against ischemia/reperfusion via STAT3-induced the inhibition of MCU opening. Basic Res Cardiol. 2019 08 28; 114(5):39.
-
Nu?ez RE, Javadov S, Escobales N. Angiotensin II-preconditioning is associated with increased PKCe/PKCd ratio and prosurvival kinases in mitochondria. Clin Exp Pharmacol Physiol. 2017 Dec; 44(12):1201-1212.
-
Wu L, Tan JL, Wang ZH, Chen YX, Gao L, Liu JL, Shi YH, Endoh M, Yang HT. ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway. J Mol Cell Cardiol. 2015 Apr; 81:150-61.
-
Nu?ez RE, Castro M, Javadov S, Escobales N. Angiotensin II and ischemic preconditioning synergize to improve mitochondrial function while showing additive effects on ventricular postischemic recovery. J Cardiovasc Pharmacol. 2014 Aug; 64(2):172-9.
-
Butler MJ, Chan W, Taylor AJ, Dart AM, Duffy SJ. Management of the no-reflow phenomenon. Pharmacol Ther. 2011 Oct; 132(1):72-85.
-
Giorgi C, Agnoletto C, Baldini C, Bononi A, Bonora M, Marchi S, Missiroli S, Patergnani S, Poletti F, Rimessi A, Zavan B, Pinton P. Redox control of protein kinase C: cell- and disease-specific aspects. Antioxid Redox Signal. 2010 Oct 01; 13(7):1051-85.
-
Gottlieb RA, Finley KD, Mentzer RM. Cardioprotection requires taking out the trash. Basic Res Cardiol. 2009 Mar; 104(2):169-80.
-
Shohet RV, Garcia JA. Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia. J Mol Med (Berl). 2007 Dec; 85(12):1309-15.